股票增持
Search documents
华新建材集团股份有限公司 关于持股5%以上股东以专项贷款和自有资金 增持公司股份计划的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-12-24 06:16
Core Viewpoint - Huaxin Group intends to increase its stake in Huaxin Cement Group Co., Ltd. by investing between RMB 200 million and RMB 400 million within six months, demonstrating confidence in the company's future development and long-term value [1][9][6]. Group 1: Shareholder Information - The increasing shareholder, Huaxin Group, holds 338,060,739 shares, representing 16.26% of the company's total share capital [4][3]. - Huaxin Group has not disclosed any shareholding increase plans in the past twelve months [5]. Group 2: Increase Plan Details - The purpose of the increase is to enhance investor confidence and company value based on Huaxin Group's strong belief in the company's future [6]. - The shares to be acquired are unrestricted circulating A-shares, and the acquisition will be conducted through centralized bidding on the Shanghai Stock Exchange [7][8]. - The total investment amount for the increase will be no less than RMB 200 million and no more than RMB 400 million [9]. Group 3: Implementation and Funding - The increase plan will be executed within six months from the announcement date, with adjustments made if the company's stock is suspended [12]. - Funding for the increase will come from Huaxin Group's own funds and a special loan of up to RMB 360 million from the Industrial and Commercial Bank of China [13]. - Huaxin Group commits not to reduce its shareholding during the implementation period of the increase plan [14]. Group 4: Regulatory Compliance - The company will continuously monitor the shareholding increase situation and fulfill its information disclosure obligations as per relevant regulations [15]. - The increase plan will not lead to changes in the company's controlling shareholder or actual controller [16].
东风集团股份(00489.HK)获摩根大通增持293.75万股
Ge Long Hui· 2025-12-18 00:53
Group 1 - JPMorgan Chase & Co. increased its stake in Dongfeng Group (00489.HK) by purchasing 2,937,500 shares at an average price of HKD 8.9047 per share, totaling approximately HKD 26.16 million [1] - Following this transaction, JPMorgan's total holdings in Dongfeng Group rose to 124,694,418 shares, increasing its ownership percentage from 4.88% to 5.00% [1]
浙商银行高管斥资2104万元,超额完成增持计划
Zhong Guo Ji Jin Bao· 2025-12-17 04:55
Group 1 - The core point of the news is that Zheshang Bank's management team has successfully completed a share buyback plan, acquiring approximately 6.71 million A-shares for a total investment of 21.04 million yuan, exceeding the minimum target by 5.22% [1][3] - The buyback plan was initiated on April 9, with a commitment to purchase at least 20 million yuan worth of shares within six months, demonstrating strong confidence in the bank's future [1][3] - Prior to the buyback, the management held about 2.61 million A-shares, which increased to approximately 9.32 million A-shares post-buyback, raising their ownership from 0.0095% to 0.0339% of the total share capital [1] Group 2 - In August, Minsheng Life Insurance increased its stake in Zheshang Bank, surpassing the 5% threshold, by acquiring 1 million H-shares for approximately 2.77 million Hong Kong dollars [2] - Zheshang Bank has attracted interest from multiple insurance companies, including Baidian Life and Taiping Life, which have made significant investments in the bank's shares over recent years [4] - As of the end of Q3 this year, Zheshang Bank reported total assets of 3.39 trillion yuan, a year-on-year increase of 1.91%, with operating income of 48.93 billion yuan and a net profit of 11.67 billion yuan [4] Group 3 - As of December 17, Zheshang Bank's A-shares were priced at 3.05 yuan per share, with a total market capitalization of 83.76 billion yuan, reflecting a year-to-date increase of approximately 9.93% [5]
丽尚国潮(600738.SH):元明控股拟增持1%-2%股份
Ge Long Hui A P P· 2025-12-16 11:55
元明控股收到中国工商银行股份有限公司浙江省分行(以下简称"工商银行浙江省分行")出具的《关于 对浙江元明控股有限公司股票增持专项贷款项目的承诺函》。工商银行浙江省分行为元明控股增持公司 股份提供不超过人民币10,000万元的贷款额度,期限3年。前述贷款仅用于元明控股通过证券交易所证 券交易系统增持股份,具体贷款事宜以双方签订的相关合同为准。 格隆汇12月16日丨丽尚国潮(600738.SH)公布,基于对公司未来持续稳定发展的信心和长期投资价值的 认可,增强投资者信心,元明控股计划自本公告披露之日起12个月内,通过上海证券交易所系统以集中 竞价方式增持公司股份,增持数量不低于总股本1%,即7,613,353股,不超过总股本的2%,即15,226,704 股(以下简称"本次增持计划")。本次增持计划不设置固定价格和价格区间,元明控股将基于对公司股 票价值的合理判断,并根据公司股票价格波动情况及资本市场整体趋势,择机实施本次增持计划。如在 本次增持计划实施期间公司发生股份发行等事项,上述增持数量范围维持不变。 ...
三花智控获GIC Private Limited增持89.88万股 每股作价约36.6港元
Xin Lang Cai Jing· 2025-12-16 00:03
香港联交所最新资料显示,12月11日,GIC Private Limited增持三花智控(02050)89.88万股,每股作价 36.5958港元,总金额约为3289.23万港元。增持后最新持股数目约为3402.48万股,持股比例为7.14%。 责任编辑:卢昱君 香港联交所最新资料显示,12月11日,GIC Private Limited增持三花智控(02050)89.88万股,每股作价 36.5958港元,总金额约为3289.23万港元。增持后最新持股数目约为3402.48万股,持股比例为7.14%。 责任编辑:卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 ...
欧派家居(603833.SH):张秋芳拟增持5000万元-1亿元股份
Ge Long Hui A P P· 2025-12-12 09:22
MACD金叉信号形成,这些股涨势不错! 格隆汇12月12日丨欧派家居(603833.SH)公布,基于对公司未来持续稳健发展的信心和长期投资价值的 认可,张秋芳女士计划自2025年12月12日起6个月内,通过上海证券交易所交易系统以集中竞价的方式 增持欧派家居A股股份,累计拟增持股份的金额不低于5,000万元,不超过10,000万元,增持比例不超过 公司总股本的1%。 张秋芳女士于2025年12月12日通过上海证券交易所交易系统以集中竞价的方式增持公司股票21万股,占 公司总股本的0.03%,本次增持成交总额1,046.64万元。 ...
金蝶国际获小摩增持约623万股 每股作价约13.51港元
Xin Lang Cai Jing· 2025-12-12 00:13
香港联交所最新资料显示,12月8日,小摩增持金蝶国际(00268)622.9962万股,每股作价13.5099港 元,总金额约为8416.62万港元。增持后最新持股数目约为1.79亿股,最新持股比例为5.04%。 责任编辑:卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 香港联交所最新资料显示,12月8日,小摩增持金蝶国际(00268)622.9962万股,每股作价13.5099港 元,总金额约为8416.62万港元。增持后最新持股数目约为1.79亿股,最新持股比例为5.04%。 责任编辑:卢昱君 ...
小摩增持金蝶国际约623万股 每股作价约13.51港元
Zhi Tong Cai Jing· 2025-12-11 11:14
香港联交所最新资料显示,12月8日,小摩增持金蝶国际(00268)622.9962万股,每股作价13.5099港元, 总金额约为8416.62万港元。增持后最新持股数目约为1.79亿股,最新持股比例为5.04%。 ...
基石药业-B现涨超4% 普吉华获纳入国家医保目录 非执行董事近日增持100万股
Zhi Tong Cai Jing· 2025-12-10 02:48
Group 1 - The core point of the article is that 基石药业's drug, 普吉华 (普拉替尼胶囊, 100mg), has been included in the latest National Medical Insurance Drug List in China, which will take effect on January 1, 2026 [1] - Following the announcement, 基石药业's stock price increased by over 4%, with a current price of 5.82 HKD and a trading volume of 24.98 million HKD [1] - Additionally, non-executive director 胡正国 purchased 1 million shares of 基石药业 at a price of 5.7546 HKD per share, totaling 5.7546 million HKD, increasing his holdings to 3.471 million shares, representing 0.24% of the company [1]
中金公司增持海伟股份(09609)17.96万股 每股作价约11.62港元
Xin Lang Cai Jing· 2025-12-08 11:28
Group 1 - CICC increased its stake in Haiwei Holdings (09609) by 179,600 shares at a price of HKD 11.622 per share, totaling approximately HKD 2.0873 million [1] - Following the increase, CICC's total shareholding in Haiwei Holdings is approximately 9.1862 million shares, representing a holding percentage of 14.24% [1]